Sequences

Sample result

GFP, read as protein

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Patents

4,303 publications in 2,986 families match these filters.

  1. US 11390882-B22022-07-19

    Expression vector

    VARIGEN BIOSCIENCES CORPORATION

    Identity 94.5%

    Best alignment

    Query 1 to 238, hit 1 to 714. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
              | ||||||||||||||||||||||||||| |||||||| |||||||||||||||||||||
    Hit     1 MRKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTTGKLPVPWPTL 180
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||| |||||||||||||||||||||||||| ||||| |||||||||||||||
    Hit   181 VTTLTYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTISFKDDGTYKTRAEVKFEGDTLV 360
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              |||||||||||||||||||||||| ||||||| ||||||||| ||||||| |||||||||
    Hit   361 NRIELKGIDFKEDGNILGHKLEYNFNSHNVYITADKQKNGIKANFKIRHNVEDGSVQLAD 540
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||||||| ||||||||||||||||||||||||||||||||
    Hit   541 HYQQNTPIGDGPVLLPDNHYLSTQSVLSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 714
    

    225 of 238 identical, no gaps.

  2. JP 2022532922-A2022-07-20

    YEAST-BASED ORAL VACCINATION

    ESPEROVAX INC

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 1582 to 2295. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1582 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1761
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1762 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1941
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1942 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 2121
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   2122 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 2295
    

    234 of 238 identical, no gaps.

  3. WO 2022154079-A2022-07-21

    Method for introducing proteins into animal cells

    National Institute of Advanced Industrial Science and Technology

    Identity 96.2%

    Best alignment

    Query 1 to 238, hit 296 to 1009. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    296 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 475
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||| ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    476 VTTLTYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 655
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               |||||||||||||||||||||||||||| ||| ||||||||||||| |||||||||||||
    Hit    656 NRIELKGIDFKEDGNILGHKLEYNYNSHKVYITADKQKNGIKVNFKTRHNIEDGSVQLAD 835
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               ||||||||||||||||||||||||| |||||||||||||||||||||||| |||||||
    Hit    836 HYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1009
    

    229 of 238 identical, no gaps.

  4. JP 2022108515-A2022-07-26

    Clinical application of HNRNPK as a therapeutic marker/target in inflammatory diseases

    National University Corporation Tokyo Medical and Dental University, National Institute of Advanced Industrial Science and Technology

    Identity 95.0%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||| ||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKLICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  || ||| ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLGYGLQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              |||||||||||||||||||||||||||||||| ||||||||| ||||||||||| |||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGGVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||| || |||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSYQSKLSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    226 of 238 identical, no gaps.

  5. MRNA TARGETING MOLECULE BASED ON N-ACETYLGALACTOSAMINE BINDING POLYPEPTIDE AND PREPARATION METHOD THEREFOR

    SHENZHEN RHEGEN BIOTECHNOLOGY CO., LTD

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 1 to 714. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 180
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 360
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   361 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 540
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   541 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 714
    

    234 of 238 identical, no gaps.

  6. MINIMAL ARRESTIN DOMAIN CONTAINING PROTEIN 1 (ARRDC1) CONSTRUCTS

    President and Fellows of Harvard College

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  7. US 11401264-B22022-08-02

    Heterocyclic compound

    Orizuru Therapeutics, Inc.

    Identity 97.1%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||| |||||| ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTFTYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              |||||||||||||||||||||||||||| ||| ||||||||||||| |||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHKVYITADKQKNGIKVNFKTRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    231 of 238 identical, no gaps.

  8. JP 2022535039-A2022-08-04

    Recombinant oncolytic virus, preparation method therefor, use thereof and medicine thereof

    ZETANG WU

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 1184 to 1897. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1184 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1363
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1364 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1543
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1544 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1723
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1724 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1897
    

    234 of 238 identical, no gaps.

  9. JP 2022114271-A2022-08-05

    Plant for production of 9, 10-alpha-ketol linolenic acid and method for production of 9, 10-alpha-ketol linolenic acid

    TOKYO INSTITUTE OF TECHNOLOGY,Kishi Kasei Co Ltd

    Identity 95.0%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||| ||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKLICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  || ||| ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLGYGLQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              |||||||||||||||||||||||||||||||| ||||||||| ||||||||||| |||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGGVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||| || |||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSYQSKLSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    226 of 238 identical, no gaps.

  10. JP 2022114681-A2022-08-08

    Method for purifying adeno-associated virus

    TOSOH corporation

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 10 to 723. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    10 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 189
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   190 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 369
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   370 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 549
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   550 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 723
    

    234 of 238 identical, no gaps.

  11. ONCOLYTIC VIRUS AND APPLICATION THEREOF, AND DRUG FOR TREATING CANCER

    Wu, Zetang

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 1184 to 1897. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1184 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1363
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1364 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1543
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1544 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1723
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1724 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1897
    

    234 of 238 identical, no gaps.

  12. JP 2022535958-A2022-08-10

    Advanced microbiome therapeutics engineered to produce serotonin in vivo

    Danmarks Tekniske Universitet, The Trustees of Columbia University in the City of New York

    Identity 97.5%

    Best alignment

    Query 1 to 238, hit 612 to 1325. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    612 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 791
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||| |||||||||||||||||| |||||||||||||||||||||
    Hit    792 VTTLTYGVQCFSRYPDHMKRHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLV 971
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               |||||||||||||||||||||||||||||||| ||||||||| |||||||||||||||||
    Hit    972 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGSVQLAD 1151
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1152 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 1325
    

    232 of 238 identical, no gaps.

  13. A NEW ONCOLYTIC VIRUS PLATFORM TO TREAT CANCERS WITH MYXOMA VIRUS

    Arizona Board of Regents on behalf of Arizona State University

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  14. RECOMBINANT ONCOLYTIC VIRUS, PREPARATION METHOD THEREFOR, USE THEREOF AND MEDICINE THEREOF

    Wu, Zetang

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 1184 to 1897. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1184 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1363
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1364 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1543
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1544 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1723
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1724 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1897
    

    234 of 238 identical, no gaps.

  15. ON-BIPOLAR CELL-SPECIFIC PROMOTERS FOR OCULAR GENE DELIVERY

    Universitat Bern

    Identity 96.6%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||| ||  || ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTFGYGLMCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||| || |||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSYQSKLSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    230 of 238 identical, no gaps.

  16. US 11414456-B22022-08-16

    Cell penetrating peptide

    Astellas Pharma Inc., National Center for Global Health and Medicine and Hiroshima University

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 715 to 1428. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    715 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 894
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    895 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1074
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1075 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1254
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1255 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1428
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  17. JP 2022536481-A2022-08-17

    COMPOSITIONS AND METHODS FOR THE TREATMENT OF DBA USING GATA1 GENE THERAPY

    THE CHILDREN'S MEDICAL CENTER CORPORATION

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 398 to 1111. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    398 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 577
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    578 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 757
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    758 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 937
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit    938 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1111
    

    234 of 238 identical, no gaps.

  18. METHOD AND COMPOSITIONS FOR REGULATED ARMORING OF CELLS

    SENTI BIOSCIENCES, INC

    Identity 95.4%Family of 2

    Best alignment and family

    Query 1 to 238, hit 1903 to 2616. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||| ||||||||||||||
    Hit   1903 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKLICTTGKLPVPWPTL 2082
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  || ||| ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   2083 VTTLGYGLQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 2262
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               |||||||||||||||||||||||||||||||| ||||||||| ||||||||||| |||||
    Hit   2263 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGGVQLAD 2442
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||| ||||||||||||||||||||||||||| |||||||
    Hit   2443 HYQQNTPIGDGPVLLPDNHYLSYQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 2616
    

    227 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  19. US 11419895-B22022-08-23

    Compositions and methods of cellular immunotherapy

    CRAGE medical Co., Limited

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  20. US 11421226-B22022-08-23

    Programmable artificial cell

    RAMOT AT TEL-AVIV UNIVERSITY LTD.

    Identity 98.3%

    Best alignment

    Query 1 to 236, hit 64 to 771. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    64 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 243
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   244 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 423
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   424 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 603
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDEL 236
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   604 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDEL 771
    

    232 of 236 identical, no gaps.

  21. US 11421259-B22022-08-23

    Cell-free protein expression using rolling circle amplification product

    Global Life Sciences Solutions Operations UK Ltd

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 157 to 870. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   157 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 336
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   337 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 516
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   517 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 696
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   697 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 870
    

    234 of 238 identical, no gaps.

  22. JP 2022537154-A2022-08-24

    CELLULAR THERAPY

    FLAGSHIP PIONEERING INNOVATIONS VI LLC

    Identity 98.7%

    Best alignment

    Query 2 to 238, hit 1 to 711. Positions start at 1 and include both ends.

    Query   2 SKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLV 61
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 SKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLV 180
    
    Query  62 TTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVN 121
              ||  ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVN 360
    
    Query 122 RIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADH 181
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   361 RIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADH 540
    
    Query 182 YQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   541 YQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 711
    

    234 of 237 identical, no gaps.

  23. JP 2022538217-A2022-09-01

    RECOMBINANT TRANSFER VECTORS FOR PROTEIN EXPRESSION IN INSECT AND MAMMALIAN CELLS

    X-Chem Inc

    Identity 96.6%

    Best alignment

    Query 1 to 238, hit 827 to 1540. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    827 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1006
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||| ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1007 VTTLTYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1186
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               |||||||||||||||||||||||||||| ||| ||||||||||||| |||||||||||||
    Hit   1187 NRIELKGIDFKEDGNILGHKLEYNYNSHKVYITADKQKNGIKVNFKTRHNIEDGSVQLAD 1366
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1367 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1540
    

    230 of 238 identical, no gaps.

  24. COMPOSITIONS AND METHODS FOR SIMULTANEOUSLY MODULATING EXPRESSION OF GENES

    VERSAMEB AG

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 1279 to 1992. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1279 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1458
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1459 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1638
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1639 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1818
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1819 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1992
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  25. WO 2022181796-A2022-09-01

    Semi-rational approach to genome evolutionary engineering in plants

    Kobe University

    Identity 99.2%

    Best alignment

    Query 1 to 238, hit 34 to 747. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    34 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 213
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   214 VTTFTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 393
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   394 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 573
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   574 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 747
    

    236 of 238 identical, no gaps.

  26. NEW METHOD FOR TARGETED EDITING OF RNA

    EDIGENE THERAPEUTICS (BEIJING) INC

    Identity 97.5%Family of 2

    Best alignment and family

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||   ||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTHGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              |||||||||||||||||||||||||||||||||||||||||| |||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKANFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    232 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  27. JP 2022129999-A2022-09-06

    Analysis method of intracellular dynamics of Fatty Acid Transporter

    University Public Corporation Osaka

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 34 to 747. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    34 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 213
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   214 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 393
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   394 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 573
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   574 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 747
    

    234 of 238 identical, no gaps.

  28. US 11434259-B22022-09-06

    Modified Zika virus NS1 protein with reduced cross-reactive immunogenicity

    IOGENETICS, LLC

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 94 to 807. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    94 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 273
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   274 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 453
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   454 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 633
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   634 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 807
    

    234 of 238 identical, no gaps.

  29. JP 2022539417-A2022-09-08

    HIV ANTIGENS AND MHC COMPLEXES

    GRITSTONE BIO INC

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, US 62/869877.

  30. WO 2022185664-A2022-09-09

    translation enhancer

    NUProtein Co Ltd

    Identity 99.6%Family of 2

    Best alignment and family

    Query 1 to 238, hit 1 to 714. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 180
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              ||||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||
    Hit   181 VTTFSYGVQCFSRYPDHMKRHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 360
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   361 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 540
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   541 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 714
    

    237 of 238 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, JP 2021-033276.

  31. JP 2022132961-A2022-09-13

    A Vector for Gene Therapy of Rheumatoid Arthritis

    Regene4T,Kyoto Prefectural University of Medicine,Tokiwa-Bio Inc, NEXT Stage Co Ltd

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 52 to 765. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    52 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 231
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   232 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 411
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   412 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 591
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   592 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 765
    

    234 of 238 identical, no gaps.

  32. COMPOSITIONS AND METHODS FOR THE PREVENTION OF S. AUREUS INFECTION

    ANTAGONIS

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 1 to 714. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 180
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              ||||||||||||||||||| |||||||||||||||||| |||||||||||||||||||||
    Hit   181 VTTFSYGVQCFSRYPDHMKRHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLV 360
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              |||||||||||||||||||||||||||||||| ||||||||| |||||||||||||||||
    Hit   361 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGSVQLAD 540
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   541 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 714
    

    234 of 238 identical, no gaps.

  33. US 11439693-B22022-09-13

    Vasoconstrictive and antibacterial combination treatment for rosacea

    MIGREOS HUMAN HEALTH B.V.

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 37 to 750. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    37 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 216
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||| || ||| ||||||| ||||||||||||||||||||||||||||||||||||||||
    Hit   217 VTTFAYGLQCFARYPDHMKRHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 396
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   397 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 576
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   577 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 750
    

    234 of 238 identical, no gaps.

  34. US 11440948-B22022-09-13

    Modified non-natural NKG2D ligands that selectively deliver attached heterologous molecules to non-natural NKG2D receptors on car-cells

    Xyphos Biosciences Inc. and THE J. DAVID GLADSTONE INSTITUTES

    Identity 97.9%

    Best alignment

    Query 1 to 238, hit 1174 to 1887. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1174 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1353
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1354 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1533
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               |||||||||||||||||||||||||||||||||||||||||| |||||||||||||||||
    Hit   1534 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKANFKIRHNIEDGSVQLAD 1713
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1714 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1887
    

    233 of 238 identical, no gaps.

  35. Composition of Prophylactic SARS-CoV-2 Vaccine

    EYEGENE INC

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  36. Composition for delivering RNA and Preparing method for the same

    EYEGENE INC

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  37. WO 2022191052-A2022-09-15

    polynucleotide

    NUProtein Co Ltd

    Identity 99.6%Family of 2

    Best alignment and family

    Query 1 to 238, hit 1 to 714. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 180
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              ||||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||
    Hit   181 VTTFSYGVQCFSRYPDHMKRHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 360
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   361 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 540
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   541 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 714
    

    237 of 238 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, JP 2021-038692.

  38. US 11447769-B22022-09-20

    Modified immune cells having enhanced function and methods for screening for same

    The Trustees of the University of Pennsylvania

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 545 to 1258. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    545 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 724
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    725 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 904
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    905 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1084
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1085 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1258
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  39. US 11447785-B22022-09-20

    Method for base editing in plants

    Institute of Genetics and Developmental Biology, Chinese Academv of Sciences

    Identity 99.2%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTFTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 717
    

    236 of 238 identical, no gaps.

  40. US 11447786-B22022-09-20

    Systems and methods for cellular reprogramming of a plant cell

    Identity 91.2%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               ||| ||||| |||| || |||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGAELFTGIVPILIELNGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              ||| |||||||||||||||||||||||||||| ||||||| |||||| ||||||||||||
    Hit   184 VTTLSYGVQCFSRYPDHMKQHDFFKSAMPEGYIQERTIFFEDDGNYKSRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||| | |||||||||| | ||||| |||||| || |||||||||||||||||||||||
    Hit   364 NRIELTGTDFKEDGNILGNKMEYNYNAHNVYIMTDKAKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||||||||||||||||||||    ||||| ||||||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMIYFGFVTAAAITHGMDELYK 717
    

    217 of 238 identical, no gaps.

  41. US 11447787-B22022-09-20

    Generation of haploid plants

    The Regents of the University of California

    Identity 99.2%

    Best alignment

    Query 1 to 238, hit 1 to 714. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 180
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||| |||||| ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 VTTFGYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 360
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   361 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 540
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   541 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 714
    

    236 of 238 identical, no gaps.

  42. JP 2022541464-A2022-09-26

    Oncolytic virus and application thereof, and drug for treating cancer

    ZETANG WU

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 1184 to 1897. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1184 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1363
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1364 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1543
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1544 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1723
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1724 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1897
    

    234 of 238 identical, no gaps.

  43. JP 2022541502-A2022-09-26

    CELL-TYPE SELECTIVE IMMUNOPROTECTION OF CELLS

    UNIVERSITY OF ROCHESTER

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  44. US 11453860-B22022-09-27

    GPC3 and ASGPR1 double-targeted transgenic immune effector cell and use thereof

    CRAGE MEDICAL CO., LIMITED

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  45. QUANTITATIVE CONTROL OF ACTIVITY OF ENGINEERED CELLS EXPRESSING UNIVERSAL IMMUNE RECEPTORS

    THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  46. CLOSED LINEAR DNA WITH MODIFIED NUCLEOTIDES

    TYRIS THERAPEUTICS, S.L

    Identity 98.3%Family of 3

    Best alignment and family

    Query 1 to 238, hit 920 to 1633. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    920 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1099
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1100 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1279
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1280 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1459
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1460 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1633
    

    234 of 238 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, EP 20382063.4.

  47. PROCESS FOR THE PRODUCTION OF CLOSED LINEAR DNA

    TYRIS THERAPEUTICS, S.L

    Identity 98.3%Family of 2

    Best alignment and family

    Query 1 to 238, hit 920 to 1633. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    920 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1099
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1100 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1279
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1280 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1459
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   1460 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1633
    

    234 of 238 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  48. WO 2022209987-A2022-10-06

    Vector for preparing a linear covalent closed DNA and a preparing method for a linear covalent closed DNA using thereof, and Preparing method for a parvovirus vector and a parvovirus vector producing cell

    KANEKA CORPORATION

    Identity 95.4%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||| ||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKLICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  || ||| ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLGYGLQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              |||||||||||||||||||||||||||||||| ||||||||| ||||||||||| |||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGGVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||| ||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSYQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    227 of 238 identical, no gaps.

  49. KCNK1 BAC-GFP transgenic animal model and manufacturing method thereof

    Korea University Research and Business Foundation

    Identity 98.3%

    Best alignment

    Query 1 to 238, hit 4 to 717. Positions start at 1 and include both ends.

    Query   1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 183
    
    Query  61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
              |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 363
    
    Query 121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 543
    
    Query 181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
              |||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
    Hit   544 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 717
    

    234 of 238 identical, no gaps.

  50. JP 2022543451-A2022-10-12

    CRISPR/CAS9 GENE EDITING SYSTEM AND APPLICATION THEREOF

    FUDAN UNIVERSITY

    Identity 97.9%

    Best alignment

    Query 1 to 238, hit 943 to 1656. Positions start at 1 and include both ends.

    Query    1 MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 60
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    943 VSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTL 1122
    
    Query   61 VTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 120
               |||  |||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1123 VTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLV 1302
    
    Query  121 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 180
               ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   1303 NRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLAD 1482
    
    Query  181 HYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK 238
               ||||||||||||||||||||||||| |||||||||||||||||||||||| |||||||
    Hit   1483 HYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITLGMDELYK 1656
    

    233 of 238 identical, no gaps.